Dresden's OncoRay Center Leads Global Cancer Treatment with World's First PCCT Scanner
Dresden's OncoRay Center has become the global pioneer in cancer treatment, acquiring the world's first photon-counting computed tomography (PCCT) scanner. This innovative device, costing two million euros and funded by the German Federal Ministry of Education and Research (BMBF), promises enhanced precision and safety in cancer treatment.
The PCCT scanner brings a significant leap forward in imaging technology. It provides more detailed, anatomically and functionally rich images, allowing for more precise treatment planning. This is particularly beneficial for gentle proton therapy, and it helps reduce the radiation dose for patients. Moreover, the new PCCT technology opens up exciting possibilities. It enables the treatment of moving tumours with the DirectSPR method, a significant advancement in tackling challenging cases.
Dresden's acquisition of this cutting-edge device reaffirms its status as an internationally leading location for medical innovations and future-oriented cancer research. The OncoRay Center, with this innovative scanner, continues to push the boundaries of cancer treatment.
The PCCT scanner's arrival in Dresden marks a milestone in cancer treatment. With its enhanced imaging capabilities and potential for treating moving tumours, it promises improved patient outcomes. The city's commitment to medical innovation and cancer research is evident, with the BMBF's two-million-euro investment in this project.
